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Whereas oxidative reactions occur in all tissues and organs, the thyroid gland constitutes such an organ, in which
oxidative processes are indispensable for thyroid hormone synthesis. It is estimated that huge amount of reactive
oxygen species, especially of hydrogen peroxide (H2O2), are produced in the thyroid under physiological conditions,
justifying the statement that the thyroid gland is an organ of “oxidative nature”. Apart from H2O2, also other free
radicals or reactive species, formed from iodine or tyrosine residues, participate in thyroid hormone synthesis. Under
physiological conditions, there is a balance between generation and detoxification of free radicals. Effective
protective mechanisms, comprising antioxidative molecules and the process of compartmentalization of potentially
toxic molecules, must have been developed in the thyroid to maintain this balance. However, with additional
oxidative abuse caused by exogenous or endogenous prooxidants (ionizing radiation being the most spectacular),
increased damage to macromolecules occurs, potentially leading to different thyroid diseases, cancer included.
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Reactive oxygen species (ROS) and free radicals participate
in numerous metabolic processes. Under physiological
conditions, there is a balance between the production and
detoxification of ROS [1,2]. However, any internal or exter-
nal pathological factor may disrupt this balance, leading to
conditions referred to as oxidative stress, playing a signifi-
cant role in the pathogenesis of several diseases [1].
The most basic reaction of oxidative stress is Fenton
reaction:
Fe2þ þ H2O2→Fe3þ þ •OH þ OH
The most harmful free radical is hydroxyl radical
(•OH), which is produced during this reaction. Both sub-
strates of Fenton reaction are normally present in cells
and possess important physiological roles.
Iron is an essential element for normal metabolic pro-
cesses, being a cofactor for many biological reactions.
On the other hand, free ionic iron, as a potent generator* Correspondence: MKarbownik@hotmail.com
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unrestricted use, distribution, and reproductioof ROS, can enhance oxidative stress. It is known that
increased iron stores in tissue result in cellular toxicity
and are associated with increased risk of cellular damage,
cancer initiation included [1,3,4].
Hydrogen peroxide (H2O2) is a form of ROS. All cells
produce continuously low or moderate amounts of H2O2
under physiological conditions. This ROS is generated
mainly by the intracellular family of NADPH oxidases
(NOX). At concentrations higher than physiological, H2O2
enhances oxidative stress, leading to increased DNA oxida-
tive damage and consequent mutagenesis [5,6].
Bivalent iron (ferrous ion; Fe2+) and/or H2O2, which initi-
ate Fenton reaction are frequently used to experimentally
induce oxidative damage to macromolecules [7-14].
Whereas oxidative reactions occur in all tissues and
organs, the thyroid gland constitutes such an organ, in
which oxidative processes are indispensable for thyroid
hormone synthesis. It is estimated that huge amount of
ROS, especially of H2O2, are produced in the thyroid
under physiological conditions, justifying the statement
that the thyroid gland is an organ of “oxidative nature”.
Hydrogen peroxide is an essential factor for thyroid hor-
mone biosynthesis. It is produced in the thyroid gland by
two isoform enzymes, dual oxidase 1 (DUOX1) and 2ka; licensee BioMed Central Ltd. This is an Open Access article distributed under
n License (http://creativecommons.org/licenses/by/2.0), which permits
n in any medium, provided the original work is properly cited.
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vincing experimental evidence found for DUOX2 [15,16].
Both DUOX enzymes are expressed in the apical plasma
membrane of thyroid follicular cells (thyrocytes) [15,16].
In turn, NOX4 playing also an important role in the syn-
thesis of H2O2 in the thyroid, acts intracellulary [17].
Hydrogen peroxide acts as an electron acceptor at each
step of thyroid hormone synthesis, namely at iodide oxida-
tion and, next, at its organification, as well as at coupling
reaction of iodotyrosines [18]. It is essential for activity of
thyroperoxidase (TPO) – the key enzyme for thyroid hor-
mone synthesis.
Thyroperoxidase is a heme-dependent protein, thus it
contains iron atoms in its structure. Hydrogen peroxide
participates in autocatalytic covalent heme binding to the
apoprotein of TPO molecule, thereby stabilizing the activ-
ity of the enzyme [19]. Hydrogen peroxide availability is
the rate-limiting step in thyroid hormone biosynthesis, al-
though H2O2 is produced in large excess compared with
the amount of iodide incorporated into proteins. This may
be due to relatively high Michaelis-Menten constant of
TPO for H2O2, which means that relatively high concen-
trations of H2O2, as a substrate, are required to properly
activate the enzyme [20,21]. Large quantities and mem-
brane permeable nature of H2O2 can lead to its diffusion
from the luminal side of the apical membrane back to the
cell. Because iron is present in TPO and H2O2 is indis-
pensable for TPO activity, the thyroid gland may be
exposed – under certain conditions – to excessive
amounts of either Fe2+ or H2O2, or both, creating favor-
able conditions for additional Fenton reaction and, conse-
quently, oxidative damage.
Thyrotropin (TSH), the main secretory and growth
stimulatory factor for the thyroid, is obviously involved in
the production of H2O2 in that gland. The major meaning
of that fact is that an increased production of H2O2, with
subsequently enhanced formation of free radicals (espe-
cially •OH), takes place in any conditions accompanied by
the increased blood TSH concentration. Thus, TSH stimu-
lation results in goitre formation and, under certain condi-
tions, in thyroid cancer initiation via the mechanism of, at
least in part, oxidative stress. In agreement with this, oxi-
dative stress creates required conditions for thyroid cell
proliferation [22,23].
Apart from H2O2, numerous other reactive species
are formed in the thyroid, such as, for example, nitric
oxide (NO•). Also particular elements of thyroid hor-
mone synthesis pathway are partially confirmed to exist
as free radicals or other reactive species, such as: tyro-
sine free radical (Tyr•), diiodotyrosyl residue radical
(DIT•), diiodotyrosyl residue radical in thyroglobulin
(Tg-DIT•), iodine radical (I•), iodinium ion (I+), hypoio-
dous acid intermediate [IO- (IOH)], and ascorbate rad-
ical (Asc•) [24].Due to potential huge oxidative stress in the thyroid
gland, effective protective mechanisms should have been
developed. An antioxidative defence system in the thyroid
gland comprises both antioxidative enzymes and free rad-
ical scavengers.
The presence of the following antioxidative enzymes in
the thyroid gland has been documented: superoxide dismu-
tase (SOD), glutathione (GSH) peroxidase (GSH-Px) and
catalase (CAT) [25]. In turn, antioxidants such as
α- and γ-tocopherols, coenzyme Q, and ascorbic acid have
also been found in the thyroids of different species. Among
antioxidants present in the thyroid, peroxiredoxins (Prxs)
seem to be of a special value, as they are involved in the
process of H2O2 elimination, when this oxygen species is
formed in response to TSH, and they protect thyroid cells
from H2O2-induced apoptosis [25,26].
The results, obtained in humans and in animal models,
suggest that oxidative damage in the thyroid, especially
this associated with thyroid cancer, is accompanied by
increased activities of antioxidative enzymes or increased
production of antioxidants, what – probably – represents
the defence mechanism [27].
Additionally, there is substantial scientific evidence that
the thyroid gland has perfectly developed a kind of autore-
gulation in terms of keeping redox balance under physio-
logical conditions. For example, thyroglobulin, a specific
thyroid glycoprotein, which provides sites for iodide orga-
nification, negatively regulates different components of
thyroid hormone synthesis, those related to oxidative
stress included (e.g. [28,29]).
Protective mechanisms against huge oxidative stress
have been developed to protect not only the thyroid gland
but also the whole organism. Specific anatomical feature of
the thyroid gland, i.e. a monolayer of thyrocytes surround-
ing the thyroid colloid, does separate the colloid from the
circulation, avoiding the leakage of ROS into the blood
and thereafter to other tissues.
Oxidative damage induced by Fenton reaction substrates
Fenton reaction substrates (Fe2+ or/and H2O2) were used
in porcine thyroid to induce oxidative damage to mem-
brane lipids (lipid peroxidation, LPO), to nuclear DNA
and to mitochondrial DNA (mtDNA).
We found in our earlier in vitro study that H2O2 is not in-
dispensable to induce LPO via Fenton reaction in porcine
ovary homogenates, which means that external Fe2+ reacted
with endogenous H2O2 [13]. Therefore we expected that
the use of only one Fenton reaction substrate would be suf-
ficient to induce LPO via Fenton reaction also in the thyroid
gland, especially that both, Fe2+/Fe3+ and H2O2 are required
for thyroid hormone synthesis, thus being presumably in
high concentrations in this gland. In opposite to our expect-
ation, none of Fenton reaction substrates, used separately,
increased LPO in the thyroid gland [30].
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gether, LPO increased significantly, however without
H2O2 concentration-dependent effect, but with clear
Fe2+-dependent effect [30]. Thus, Fe2+ was found to be a
stronger damaging factor to membrane lipids than H2O2,
but it still required the presence of external H2O2 to re-
veal damaging effect. These unexpected results can be
explained by the fact that the thyroid gland is specialized
to compartmentalize H2O2, making it unavailable for any
undesirable reactions. Such an explanation is supported
by results mentioned above and showing that the in-
crease of LPO occurring in the presence of both exogen-
ous Fenton reaction substrates did not depend on the
concentration of H2O2. In other words, the addition of
small amounts of H2O2, resulting in its low concentra-
tions such as 10-5 mM (the lowest concentration used in
the above cited study), was sufficient, but still indispens-
able, to induce LPO in thyroid homogenates. It should
be stressed that the lowest H2O2 concentration used in
the study (10-5 mM) belongs to the range reached
physiologically in cells – they vary from 0.001 μM to
15 μM [5,31], however other than thyroid cells. Thus,
not compartmentalized H2O2 concentration in the thy-
roid is possibly much lower than in other tissues, but
that should be experimentally proved.
Interestingly, when we induced LPO by Fenton reac-
tion in porcine thyroid homogenates [12] (in this earlier
study we did not check concentration-dependent effect
of Fenton reaction substrates), melatonin (N-acetyl-5-
methoxytryptamine), being perfectly documented as an
effective antioxidant [11,32-34], prevented LPO with the
lowest effective concentration of 0.25 mM. At the same
time melatonin did not affect the basal LPO [12], which
supports the statement that this indoleamine is an
excellent antioxidant.
When nuclear and mtDNA were exposed to Fenton reac-
tion substrates, they appeared to be more sensitive than
membrane lipids, i.e. 8-oxo-7,8-dihydro-20-deoxyguanosine
(8-oxodG) concentration (DNA damage index) increased
in the presence of only one Fenton reaction substrate
[30,35]. Again, Fe2+ appeared to be more stronger dam-
aging factor to both, nuclear DNA [30] and mtDNA [35],
than was H2O2. The most important observation concern-
ing oxidative damage to nuclear DNA and mtDNA is that
the background level of 8-oxodG in mtDNA [35] was ap-
proximately 10 times higher than that one in nuclear DNA
[30]. This disproportion between mtDNA and nuclear
DNA is in agreement with results found in other tissues
[36,37]. Concerning our observation on high mtDNA sensi-
tivity to oxidative stress and the fact that thyroid oncocytic
tumours are composed of cells filled – almost exclusively –
with mitochondria characterized by molecular and enzym-
atic abnormalities, the following hypothesis can be formed.
Whereas huge oxidative stress in the thyroid is hypothesizedto play a crucial role in thyroid cancer, especially in papillary
thyroid carcinoma, initiation [38], high oxidative damage to
mtDNA in the thyroid allow to propose that oxidative pro-
cesses substantially contribute to formation of thyroid
tumors, with oxyphilic type of follicular thyroid carcinoma
being of special significance [35].
In rat thyroid cell line (PCCl3), H2O2, used in concentra-
tions 0.1-0.5 mM, caused a large number of DNA single-
strand breaks and double-strand breaks. These data
support the hypothesis that the generation of H2O2 in the
thyroid could also play a role in mutagenesis, particularly
in the case of antioxidant deficiency [39]. Additionally,
these results [39] are in agreement with our findings
[30,35] showing, that the use of only one Fenton reaction
substrate, in this case of H2O2, is sufficient to induce oxi-
dative damage to DNA.Oxidative damage induced by potassium bromate (KBrO3)
Potassium bromate (KBrO3) has been classified by Inter-
national Agency for Research on Cancer (IARC) as a
compound belonging to the group 2B of carcinogens (a
possible human carcinogen) [40]. It has been demon-
strated to cause, among others, follicular cell tumors in
rat thyroid [41,42]. In our in vivo model single injection
of KBrO3 (110 mg/kg b.w., i.p.) expectedly induced LPO
in the rat thyroid gland [43]. That prooxidative effect
of KBrO3 was completely prevented by melatonin
(0.0645 mmol/kg b.w., i.p., twice daily, for 10 days), but
also by indole-3-propionic acid (IPA) (0.0645 mmol/kg
b.w., i.p., twice daily, for 10 days) – an indole substance
with chemical structure similar to melatonin, and also
by propylthiouracil (PTU) (0.025% solution in drinking
water, for 10 days) – an antithyroid drug possessing cer-
tain antioxidative properties [43].
In in vitro study KBrO3 induced – in concentration-
dependent manner (for concentrations of 5 mM and
10 mM) – LPO in porcine thyroid homogenates [43]. How-
ever, LPO caused by KBrO3 (5 mM) was not prevented by
melatonin, and also by the IPA. Only PTU (in concentra-
tions of 5.0, 7.5 and 10.0 mM) significantly reduced KBrO3-
induced LPO in homogenates of porcine thyroids [43].
The explanation of this apparent discrepancy (between
in vivo and in vitro study) may be as following. First, the
lack of protective effect of potential antioxidants in the
in vitro conditions does not exclude their ability to reveal
such an effect in living organisms; this observation has
been confirmed for melatonin and IPA in the above
mentioned study [43]. Second, molecules, like melatonin
and IPA, act as endogenous electron donors, primarily
detoxifying ROS; this mechanism may be responsible for
the high efficacy of antioxidative action of melatonin and
IPA in vivo. Because these indoles do not possess the
redox-active hydroxyl group at position 5 of the indole
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therefore, they are either poorly protective or not effect-
ive in vitro [44].
It should be also stressed, that the protective effects of
PTU against KBrO3-induced LPO in the thyroid in vivo
and in vitro only allow proceeding into details of the anti-
oxidative mechanism of PTU action, but they do not allow
recommending PTU for protection specifically against oxi-
dative damage and against thyroid cancer.
Oxidative damage induced by nitrobenzene
Nitrobenzene is classified by IARC as possibly carcinogenic
to humans (group 2B) [45]. It has been demonstrated, that
nitrobenzene may induce thyroid follicular adenomas in
mice, or both follicular thyroid adenomas and carcinomas
in rats [46]. In our in vitro model nitrobenzene in concen-
trations of 7.5 and 10.0 mM induced LPO in porcine
thyroid homogenates [Zasada and Karbownik-Lewińska,
unpublished observations]. Nitrobenzene (7.5 mM) induced
LPO was effectively prevented by melatonin, with its lowest
effective concentration of 0.0001 mM. It should be stressed
that this concentration of melatonin is only two orders of
magnitude higher than physiological blood concentration in
humans [Zasada and Karbownik-Lewińska, unpublished
observations]. PTU also significantly reduced nitrobenzene-
induced LPO, but only in its highest used concentration of
7.5 mM [Zasada and Karbownik-Lewińska, unpublished
observations].
Oxidative damage caused by components of
somatotrophic axis
The increased incidence of cancer of different kind [47],
the presence of goiter and thyroid cancer [48,49] in acro-
megalic patients and certain experimental evidence of
growth hormone (GH) signalling effects on thyroid growth
[50], and also potential cancerogenic properties of insulin-
like growth factor I (IGF-I) justify to evaluate effects of
somatotrophic axis components on oxidative damage to
macromolecules, also in the thyroid.
In our in vitro study, GH, used in concentrations of 100,
10, 1.0, 0.01 μg/mL, and/or IGF-I, used in concentrations
of 1000, 100, 10, 1.0, 0.1, 0.01, 0.001, 0.0001 μg/mL, did
not change the basal LPO in porcine thyroid homogenates
[51]. This effect was unexpected, but very desirable [51].
This finding may indicate that GH and IGF-I are very
promising agents in terms of protection against oxidative
damage under physiological conditions. At the same time,
both GH and IGF-I significantly affected Fenton reaction-
induced LPO. Namely, GH, in the lowest used concentra-
tions (0.001 and 0.0001 μg/mL), prevented oxidative
damage caused by Fenton reaction, thus revealing antioxi-
dative effects; those effects of GH were the only protective
effect against experimentally induced LPO, observed in
this study. In other – higher (100, 10, 1.0, 0.1, 0.01 μg/mL)– used concentrations, we observed prooxidative effect of
GH, i.e. GH enhanced Fenton reaction-induced LPO. In
turn, IGF-I in all used concentrations enhanced Fenton
reaction-induced LPO in porcine thyroid homogenates
[51].
The fact that both GH and IGF-I may enhance oxidative
damage initiated by other prooxidants does not support
the idea that they may serve as protective factors under
pathological conditions (other than GH deficiency).
Oxidative damage caused by deficiency of antioxidative
components
The thyroid gland is characterized by relatively high level
of selenium [25,52]. Selenoproteins seem to be crucial for
antioxidative protection in the thyroid, for thyroid
hormone synthesis and for the global integrity of thyro-
cytes, as they are present in antioxidative enzymes such as
GSH-Px, thioredoxin reductases, and also in deiodinases
[25,52]. When murine thyroids were experimentally
depleted of selenoproteins at gene level, expectedly was
found the increased oxidative damage to membrane lipids
[evaluated by the increased 4-hydroxynonenal (4-HNE)
level], and to proteins (evaluated by increased 3-nitro-
tyrosine level) [53]. Although oxidative damage to DNA
was not evaluated in this study, it is expected that this
molecule in the thyroid is also damaged under conditions
of selenium deficiency. The above results clearly suggest
that under physiological conditions selenoproteins protect
thyrocytes from oxidative damage to macromolecules.
Oxidative damage in thyroid cancer
The level of oxidative damage to macromolecules was
found to be increased in cancerous thyroid tissue.
For example, in case of human thyroid diseases – non-
toxic nodular goitre, carcinomas (follicular and papillary)
and follicular adenoma – the highest level of LPO pro-
ducts was found in carcinomas; interestingly, it was also
increased in follicular adenoma. Those changes were
accompanied by increased activities of antioxidative
enzymes, such as SOD, GSH-Px, and CAT, especially in
case of thyroid carcinomas [54], and also in follicular thy-
roid adenomas and carcinomas [55].
In agreement with the above, increased levels of
8-oxodG and of 4-HNE were found not only in the cancer-
ous tissues, such as follicular thyroid carcinoma and papil-
lary thyroid carcinoma, but also in follicular thyroid
adenoma [56]. Such findings [54-56] suggest that oxidative
damage to macromolecules may be an early event of thy-
roid cancer that may affect disease progression.
Whereas the level of antioxidative defence increases in
differentiated thyroid cancer, a decreased expression of
mRNA encoding for CATand SOD were found in anaplas-
tic thyroid carcinoma, when compared to histopathologic-
ally unchanged thyroid tissue and to differentiated thyroid
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diseases, like e.g. anaplastic carcinoma, the defence
mechanisms remain inactive or depressed.
Conclusions
The increased oxidative damage to macromolecules in the
thyroid occur in response to different exogenous prooxi-
dants. The contribution of this oxidative damage to the de-
velopment of thyroid diseases, cancer included, should be
considered.
Abbreviations
Asc•: Ascorbate radical; CAT: Catalase; DIT•: Diiodotyrosyl residue radical;
DUOX: Dual oxidase; Fe2+: Ferrous ion; GH: Growth hormone;
GSH: Glutathione; GSH-Px: Glutathione peroxidase; 4-HNE: 4-hydroxynonenal;
H2O2: Hydrogen peroxide; I
•: Iodine radical; I+: Iodinium ion;
IARC: International Agency for Research on Cancer; IGF-I: Insulin-like growth
factor I; [IO- (IOH)]: Hypoiodous acid intermediate; IPA: Indole-3-propionic
acid; KBrO3: Potassium bromate; LPO: Lipid peroxidation;
mtDNA: Mitochondrial DNA; NADPH: Nicotinamide adenine dinucleotide
phosphate; NO•: Nitric oxide; NOX: NADPH oxidase; 8-oxodG: 8-oxo-7,8-
dihydro-20-deoxyguanosine; •OH: Hydroxyl radical; Prxs: Peroxiredoxins;
PTU: Propylthiouracil; ROS: Reactive oxygen species; SOD: Superoxide
dismutase; Tg-DIT•: Diiodotyrosyl residue radical in thyroglobulin;
TPO: Thyroperoxidase; TSH: Thyrotropin; Tyr•: Tyrosine free radical.
Competing interests
The Authors declare that there is no conflict of interest.
Authors’ contributions
MKL wrote the manuscript and supervised preparation of the final version of
the manuscript; AKB was involved in preparation of the manuscript. Both
authors read and approved the final manuscript.
Received: 6 December 2012 Accepted: 10 December 2012
Published: 27 December 2012
References
1. Halliwell B: Free radicals and antioxidants: updating a personal view.
Nutr Rev 2012, 70:257–265.
2. Ray PD, Huang BW, Tsuji Y: Reactive oxygen species (ROS) homeostasis
and redox regulation in cellular signaling. Cell Signal 2012, 24:981–990.
3. Akhtar MJ, Kumar S, Murthy RC, Ashquin M, Khan MI, Patil G, Ahmad I:
The primary role of iron-mediated lipid peroxidation in the differential
cytotoxicity caused by two varieties of talc nanoparticles on A549 cells
and lipid peroxidation inhibitory effect exerted by ascorbic acid.
Toxicol In Vitro 2010, 24:1139–1147.
4. Circu ML, Aw TY: Reactive oxygen species, cellular redox systems, and
apoptosis. Free Radic Biol Med 2010, 48:749–762.
5. Song Y, Driessens N, Costa M, De Deken X, Detours V, Corvilain B, Maenhaut C,
Miot F, Van Sande J, Many MC, Dumont JE: Roles of hydrogen peroxide in
thyroid physiology and disease. J Clin Endocrinol Metab 2007,
92:3764–3773.
6. Braun J, Hüttelmaie S: Pathogenic mechanisms of deregulated microRNA
expression in thyroid carcinomas of follicular origin. Thyroid Res 2011,
4(Suppl 1):S1.
7. Cabrera J, Burkhardt S, Tan DX, Manchester LC, Karbownik M, Reiter RJ:
Autoxidation and toxicant-induced oxidation of lipid and DNA in
monkey liver: reduction of molecular damage by melatonin.
Pharmacol Toxicol 2001, 89:225–230.
8. Gitto E, Tan DX, Reiter RJ, Karbownik M, Manchester LC, Cuzzocrea S, Fulia F,
Barberi I: Individual and synergistic antioxidative actions of melatonin: studies
with vitamin E, vitamin C, glutathione and desferrioxamine (desferoxamine) in
rat liver homogenates. J Pharm Pharmacol 2001, 53:1393–1401.
9. Karbownik M, Reiter RJ, Garcia JJ, Tan D: Melatonin reduces
phenylhydrazine-induced oxidative damage to cellular membranes:
evidence for the involvement of iron. Int J Biochem Cell Biol 2000,
32:1045–1054.10. Karbownik M, Gitto E, Lewiński A, Reiter RJ: Relative efficacies of indole
antioxidants in reducing autoxidation and iron-induced lipid
peroxidation in hamster testes. J Cell Biochem 2001, 81:693–699.
11. Karbownik M, Lewiński A, Reiter RJ: Anticarcinogenic actions of melatonin
which involve antioxidative processes: Comparison with other antioxidants.
Int J Biochem Cell Biol 2001, 33:735–753.
12. Karbownik M, Lewiński A: Melatonin reduces Fenton-induced lipid
peroxidation in porcine thyroid tissue. J Cell Biochem 2003, 90:806–811.
13. Karbownik-Lewińska M, Stępniak J, Krawczyk J, Zasada K, Szosland J, Gesing
A, Lewiński A: External hydrogen peroxide is not indispensable for
experimental induction of lipid peroxidation via Fenton reaction in
porcine ovary homogenates. Neuro Endocrinol Lett 2010, 31:343–347.
14. Karbownik M, Reiter RJ, Burkhardt S, Gitto E, Tan DX, Lewiński A: Melatonin
attenuates estradiol-induced oxidative damage to DNA: relevance for
cancer prevention. Exp Biol Med (Maywood) 2001, 226:707–712.
15. Rigutto S, Hoste C, Grasberger H, Milenkovic M, Communi D, Dumont JE,
Corvilain B, Miot F, De Deken X: Activation of dual oxidases Duox1 and
Duox2: differential regulation mediated by camp-dependent protein
kinase and protein kinase C-dependent phosphorylation.
J Biol Chem 2009, 284:6725–6734.
16. Leto TL, Morand S, Hurt D, Ueyama T: Targeting and regulation of reactive
oxygen species generation by Nox family NADPH oxidases.
Antioxid Redox Signal 2009, 11:2607–2619.
17. Weyemi U, Caillou B, Talbot M, Ameziane-El-Hassani R, Lacroix L,
Lagent-Chevallier O, Al Ghuzlan A, Roos D, Bidart JM, Virion A, Schlumberger
M, Dupuy C: Intracellular expression of reactive oxygen species-
generating NADPH oxidase NOX4 in normal and cancer thyroid tissues.
Endocr Relat Cancer 2010, 17:27–37.
18. Karbownik M, Lewiński A: The role of oxidative stress in physiological and
pathological processes in the thyroid gland; possible involvement in
pineal-thyroid interactions. Neuro Endocrinol Lett 2003, 24:293–303.
19. Fayadat L, Niccoli-Sire P, Lanet J, Franc JL: Role of heme in intracellular
trafficking of thyroperoxidase and involvement of H2O2 generated at the
apical surface of thyroid cells in autocatalytic covalent heme binding.
J Biol Chem 1999, 274:10533–10538.
20. Hosoya T, Morrison M: The isolation and purification of thyroid
peroxidase. J Biol Chem 1967, 242:2828–2836.
21. Corvilain B, Laurent E, Lecomte M, Van Sande J, Dumont JE: Role of the
cyclic adenosine 3,5-monophosphate and the phosphatidylinositol-Ca2+
cascades in mediating the effects of thyrotropin and iodide on hormone
synthesis and secretion in human thyroid slices. J Clin Endocrinol Metab
1994, 79:152–159.
22. Poncin S, Gérard AC, Boucquey M, Senou M, Calderon PB, Knoops B,
Lengelé B, Many MC, Colin IM: Oxidative stress in the thyroid gland: from
harmlessness to hazard depending on the iodine content.
Endocrinology 2008, 149:424–433.
23. Poncin S, Van Eeckoudt S, Humblet K, Colin IM, Gérard AC:
Oxidative stress: a required condition for thyroid cell proliferation.
Am J Pathol 2010, 176:1355–1363.
24. Taurog A: Hormone synthesis. In The Thyroid. Edited by Braverman LE,
Utiger RD. Philadelphia: Lippincott Williams & Wilkins; 2000:52–90.
25. Köhrle J, Gärtner R: Selenium and thyroid. Best Pract Res Clin Endocrinol
Metab 2009, 23:815–827.
26. Kovacic P, Edwards C: Integrated approach to the mechanisms of thyroid
toxins: electron transfer, reactive oxygen species, oxidative stress, cell
signaling, receptors, and antioxidants. J Recept Signal Transduct Res 2010,
30:133–142.
27. Wang D, Feng JF, Zeng P, Yang YH, Luo J, Yang YW: Total
oxidant/antioxidant status in sera of patients with thyroid cancers.
Endocr Relat Cancer 2011, 18:773–782.
28. Suzuki K, Lavaroni S, Mori A, Ohta M, Saito J, Pietrarelli M, Singer DS, Kimura
S, Katoh R, Kawaoi A, Kohn LD: Autoregulation of thyroid-specific gene
transcription by thyroglobulin. Proc Natl Acad Sci USA 1998,
95:8251–8256.
29. Yoshihara A, Hara T, Kawashima A, Akama T, Tanigawa K, Wu H, Sue M,
Ishido Y, Hiroi N, Ishii N, Yoshino G, Suzuki K: Regulation of dual oxidase
expression and H2O2 production by thyroglobulin.
Thyroid 2012, 22:1054–1062.
30. Stępniak J, Lewiński A, Karbownik-Lewińska M: Membrane lipids and nuclear
DNA are differently susceptive to Fenton reaction substrates in porcine
thyroid. Toxicol In Vitro 2013, 27:71–78.
Karbownik-Lewińska and Kokoszko-Bilska Thyroid Research 2012, 5:25 Page 6 of 6
http://www.thyroidresearchjournal.com/content/5/1/2531. Schröder E, Eaton P: Hydrogen peroxide as an endogenous mediator and
exogenous tool in cardiovascular research: issues and considerations.
Curr Opin Pharmacol 2008, 8:153–159.
32. Galano A, Tan DX, Reiter RJ: Melatonin as a natural ally against oxidative
stress: a physicochemical examination. J Pineal Res 2011, 51:1–16.
33. Bonnefont-Rousselot D, Collin F: Melatonin: action as antioxidant and
potential applications in human disease and aging. Toxicology 2010,
278:55–67.
34. Karbownik M, Reiter RJ: Antioxidative effects of melatonin in protection
against cellular damage caused by ionizing radiation. Proc Soc Exp Biol
Med 2000, 225:9–22.
35. Karbownik-Lewińska M, Stępniak J, Lewiński A: High level of oxidized
nucleosides in thyroid mitochondrial DNA; damaging effects of Fenton
reaction substrates. Thyroid Res. in press.
36. Richter C, Park JW, Ames BN: Normal oxidative damage to mitochondrial
and nuclear DNA is extensive. Proc Natl Acad Sci USA 1988, 85:6465–6467.
37. Yakes FM, Van Houten B: Mitochondrial DNA damage is more extensive
and persists longer than nuclear DNA damage in human cells following
oxidative stress. Proc Natl Acad Sci USA 1997, 94:514–519.
38. Detours V, Delys L, Libert F, Weiss Solís D, Bogdanova T, Dumont JE, Franc B,
Thomas G, Maenhaut C: Genome-wide gene expression profiling suggests
distinct radiation susceptibilities in sporadic and
post-Chernobyl papillary thyroid cancers. Br J Cancer 2007, 97:818–825.
39. Driessens N, Versteyhe S, Ghaddhab C, Burniat A, De Deken X, Van Sande J,
Dumont JE, Miot F, Corvilain B: Hydrogen peroxide induces DNA
single- and double-strand breaks in thyroid cells and is therefore a
potential mutagen for this organ. Endocr Relat Cancer 2009, 16:845–856.
40. IARC monographs on the evaluation of carcinogenic risks to humans:
Potassium bromate. Lyon: IARC 1986, 40:207–220.
41. Kurokawa Y, Maekawa A, Takahashi M, Hayashi Y: Toxicity and
carcinogenicity of potassium bromate - a new renal carcinogen. Environ
Health Perspect 1990, 87:309–335.
42. Wolf DC, Crosby LM, George MH, Kilburn SR, Moore TM, Miller RT, DeAngelo
AB: Time- and dose-dependent development of potassium bromate-
induced tumors in male Fischer 344 rats. Toxicol Pathol 1998, 26:724–729.
43. Karbownik M, Stasiak M, Zasada K, Zygmunt A, Lewiński A: Comparison of
potential protective effects of melatonin, indole-3-propionic acid and
propylthiouracil against lipid peroxidation caused by potassium bromate
in the thyroid gland. J Cell Biochem 2005, 95:131–138.
44. Poeggeler B, Pappolla MA, Hardeland R, Rassoulpour A, Hodgkins PS,
Guidetti P, Schwarcz R: Indole-3-propionate: a potent hydroxyl radical
scavenger in rat brain. Brain Res 1999, 815:382–388.
45. IARC monographs on the evaluation of carcinogenic risks to humans:
Nitrobenzene. Lyon: IARC 1996, 65:381–408.
46. Cattley RC, Everitt JI, Gross EA, Moss OR, Hamm TE Jr, Popp JA:
Carcinogenicity and toxicity of inhaled nitrobenzene in B6C3F1 mice and
F344 and CD rats. Fundam Appl Toxicol 1994, 22:328–340.
47. Jenkins PJ, Mukherjee A, Shalet SM: Does growth hormone cause cancer?
Clin Endocrinol (Oxf ) 2006, 64:115–121.
48. Golkowski F, Krzentowska-Korek A, Baldys-Waligorska A, Hubalewska-
Dydejczyk A: Goiter, cardiovascular and metabolic disorders in patients
with acromegaly. Endocr Regul 2011, 45:191–197.
49. Dos Santos MC, Nascimento GC, Nascimento AG, Carvalho VC, Lopes MH,
Montenegro R, Montenegro R Jr, Vilar L, Albano MF, Alves AR, Parente CV,
Dos Santos Faria M: Thyroid cancer in patients with acromegaly:
a case–control study. Pituitary. in press.
50. Gesing A, Bartke A, Masternak MM, Lewiński A, Karbownik-Lewińska M:
Decreased thyroid follicle size in dwarf mice may suggest the role of growth
hormone signaling in thyroid growth regulation. Thyroid Res 2012, 5:7.
51. Kokoszko A, Dąbrowski J, Lewiński A, Karbownik-Lewińska M: Effects of
growth hormone and insulin-like growth factor-I on the iron-induced
lipid peroxidation in the rat liver and porcine thyroid homogenates.
Neuro Endocrinol Lett 2010, 31:517–523.
52. Köhrle J, Jakob F, Contempré B, Dumont JE: Selenium, the thyroid, and the
endocrine system. Endocr Rev 2005, 26:944–984.
53. Chiu-Ugalde J, Wirth EK, Klein MO, Sapin R, Fradejas-Villar N, Renko K,
Schomburg L, Köhrle J, Schweizer U: Thyroid function is maintained
despite increased oxidative stress in mice lacking selenoprotein
biosynthesis in thyroid epithelial cells. Antioxid Redox Signal 2012,
17:902–913.54. Sadani GR, Nadkarni GD: Role of tissue antioxidant defence in thyroid
cancers. Cancer Lett 1996, 109:231–235.
55. Yanagawa T, Ishikawa T, Ishii T, Tabuchi K, Iwasa S, Bannai S, Omura K, Suzuki
H, Yoshida H: Peroxiredoxin I expression in human thyroid tumors. Cancer
Lett 1999, 145:127–132.
56. Young O, Crotty T, O’Connell R, O’Sullivan J, Curran AJ: Levels of oxidative
damage and lipid peroxidation in thyroid neoplasia. Head Neck 2010,
32:750–756.
57. Hasegawa Y, Takano T, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, Amino
N: Decreased expression of catalase mRNA in thyroid anaplastic
carcinoma. Jpn J Clin Oncol 2003, 33:6–9.
doi:10.1186/1756-6614-5-25
Cite this article as: Karbownik-Lewińska and Kokoszko-Bilska: Oxidative
damage to macromolecules in the thyroid - experimental evidence.
Thyroid Research 2012 5:25.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
